|
1
|
Scopa CD: Histopathology of thyroid
tumors. An overview. Hormones (Athens). 3:100–110. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Holmes L Jr, Hossain J and Opara F:
Pediatric thyroid carcinoma incidence and temporal trends in the
USA (1973–2007): Race or shifting diagnostic paradigm? ISRN Oncol.
2012:9061972012.PubMed/NCBI
|
|
3
|
Faquin WC: The thyroid gland: Recurring
problems in histologic and cytologic evaluation. Arch Pathol Lab
Med. 132:622–632. 2008.PubMed/NCBI
|
|
4
|
Navas-Carrillo D, Rios A, Rodriguez JM,
Parrilla P and Orenes-Piñero E: Familial nonmedullary thyroid
cancer: Screening, clinical, molecular and genetic findings.
Biochim Biophys Acta. 1846:468–476. 2014.PubMed/NCBI
|
|
5
|
Howlader N, Noone AM, Krapcho M, Miller D,
Brest A, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, et al:
SEER Cancer Statistics Review, 1975–2016. National Cancer
Institute; Bethesda, MD: https://seer.cancer.gov/csr/1975_2016/based on
November 2018 SEER data submission, posted to the SEER web site.
April. 2019
|
|
6
|
Rahbari R, Zhang L and Kebebew E: Thyroid
cancer gender disparity. Future Oncol. 6:1771–1779. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Paricharttanakul NM, Saharat K,
Chokchaichamnankit D, Punyarit P, Srisomsap C and Svasti J:
Unveiling a novel biomarker panel for diagnosis and classification
of well-differentiated thyroid carcinomas. Oncol Rep. 35:2286–2296.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Villanueva J, Martorella AJ, Lawlor K,
Philip J, Fleisher M, Robbins RJ and Tempst P: Serum peptidome
patterns that distinguish metastatic thyroid carcinoma from
cancer-free controls are unbiased by gender and age. Mol Cell
Proteomics. 5:1840–1852. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang JX, Yu JK, Wang L, Liu QL, Zhang J
and Zheng S: Application of serum protein fingerprint in diagnosis
of papillary thyroid carcinoma. Proteomics. 6:5344–5349. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cohen A, Wang E, Chisholm KA, Kostyleva R,
O'Connor-McCourt M and Pinto DM: A mass spectrometry-based plasma
protein panel targeting the tumor microenvironment in patients with
breast cancer. J Proteomics. 81:135–147. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Egertson JD, Kuehn A, Merrihew GE, Bateman
NW, MacLean BX, Ting YS, Canterbury JD, Marsh DM, Kellmann M,
Zabrouskov V, et al: Multiplexed MS/MS for improved
data-independent acquisition. Nat Methods. 10:744–746. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Maan M, Peters JM, Dutta M and Patterson
AD: Lipid metabolism and lipophagy in cancer. Biochem Biophys Res
Commun. 504:582–589. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tamura K, Horikawa M, Sato S, Miyake H and
Setou M: Discovery of lipid biomarkers correlated with disease
progression in clear cell renal cell carcinoma using desorption
electrospray ionization imaging mass spectrometry. Oncotarget.
10:1688–1703. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ma MZ, Yuan SQ, Chen YM and Zhou ZW:
Preoperative apolipoprotein B/apolipoprotein A1 ratio: A novel
prognostic factor for gastric cancer. Onco Targets Ther.
11:2169–2176. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang D, Cheng X, Yu S, Qiu L, Lian X, Guo
X, Hu Y, Lu S, Yang G and Liu H: Data mining: Seasonal and
temperature fluctuations in thyroid-stimulating hormone. Clin
Biochem. 60:59–63. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Thompson L: World Health Organization
classification of tumours: Pathology and genetics of head and neck
tumours. Ear Nose Throat J. 85:742006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Long J, Zhang CJ, Zhu N, Du K, Yin YF, Tan
X, Liao DF and Qin L: Lipid metabolism and carcinogenesis, cancer
development. Am J Cancer Res. 8:778–791. 2018.PubMed/NCBI
|
|
18
|
Nikitin PV, Potapov AA, Ryzhova MV,
Shurkhay VA, Kulikov EE, Zhvanskiy ES, Popov IA and Nikolaev EN:
The role of lipid metabolism disorders, atypical isoforms of
protein kinase C, and mutational status of cytosolic and
mitochondrial forms of isocitrate dehydrogenase in carcinogenesis
of glial tumors. Zh Vopr Neirokhir Im N N Burdenko. 82:112–120.
2018.(In Russian). View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ulmer H, Borena W, Rapp K, Klenk J,
Strasak A, Diem G, Concin H and Nagel G: Serum triglyceride
concentrations and cancer risk in a large cohort study in Austria.
Br J Cancer. 101:1202–1206. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Martin RM, Vatten L, Gunnell D, Romundstad
P and Nilsen TI: Components of the metabolic syndrome and risk of
prostate cancer: The HUNT 2 cohort, Norway. Cancer Causes Control.
20:1181–1192. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Breslow JL, Ross D, McPherson J, Williams
H, Kurnit D, Nussbaum AL, Karathanasis SK and Zannis VI: Isolation
and characterization of cDNA clones for human apolipoprotein A-I.
Proc Natl Acad Sci USA. 79:6861–6865. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cine N, Baykal AT, Sunnetci D, Canturk Z,
Serhatli M and Savli H: Identification of ApoA1, HPX and POTEE
genes by omic analysis in breast cancer. Oncol Rep. 32:1078–1086.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hong TT, Shen D, Chen XP, Wu XH and Hua D:
Preoperative serum lipid profile and outcome in nonmetastatic
colorectal cancer. Chronic Dis Transl Med. 2:241–249. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhao R, Cheng G, Wang B, Qin C, Liu Y, Pan
Y, Wang J, Hua L, Zhu W and Wang Z: BMI and serum lipid parameters
predict increasing risk and aggressive prostate cancer in Chinese
people. Oncotarget. 8:66051–66060. 2017.PubMed/NCBI
|
|
25
|
Liu BZ, Tao L, Chen YZ, Li XZ, Dong YL, Ma
YJ, Li SG, Li F and Zhang WJ: Preoperative body mass index, blood
albumin and triglycerides predict survival for patients with
gastric cancer. PLoS One. 11:e01574012016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
You S, Zhong C, Xu J, Han Q, Zhang X, Liu
H, Zhang Y, Shi J, Huang Z, Xiao G, et al: LDL-C/HDL-C ratio and
risk of all-cause mortality in patients with intracerebral
hemorrhage. Neurol Res. 38:903–908. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liao T, Wang YJ, Hu JQ, Wang Y, Han LT, Ma
B, Shi RL, Qu N, Wei WJ, Guan Q, et al: Histone methyltransferase
KMT5A gene modulates oncogenesis and lipid metabolism of papillary
thyroid cancer in vitro. Oncol Rep. 39:2185–2192.
2018.PubMed/NCBI
|
